AVBP · ArriVent BioPharma, Inc.
$31.14
-0.21 (-0.67%)
At close · Aug 26
Market Cap
$1.52B
Shares
49.31M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-12 | 2026-08-11 | |
| 10-Q | 2026-08-12 | 2026-06-30 | |
| 8-K | 2026-06-22 | 2026-06-18 | |
| 8-K | 2026-05-11 | — | |
| 10-Q | 2026-05-11 | 2026-03-31 | |
| 8-K | 2026-05-11 | — | |
| DEF 14A | 2026-04-28 | 2026-06-18 | |
| 8-K | 2026-03-17 | — | |
| 10-K | 2026-03-05 | 2025-12-31 | |
| 8-K | 2026-03-05 | — | |
| 10-Q | 2025-11-10 | 2025-09-30 | |
| 8-K | 2025-11-10 | — | |
| 8-K | 2025-09-09 | — | |
| 8-K | 2025-08-11 | — | |
| 10-Q | 2025-08-11 | 2025-06-30 | |
| 8-K | 2025-07-21 | — | |
| 8-K | 2025-07-02 | 2025-07-01 | |
| 8-K | 2025-06-23 | — | |
| 8-K | 2025-06-20 | 2025-06-18 | |
| 8-K | 2025-05-12 | — | |
| 10-Q | 2025-05-12 | 2025-03-31 | |
| 8-K | 2025-04-28 | 2025-04-23 | |
| DEF 14A | 2025-04-28 | 2025-06-18 | |
| 8-K | 2025-03-13 | 2025-03-11 | |
| 8-K | 2025-03-03 | — | |
| 10-K | 2025-03-03 | 2024-12-31 | |
| 8-K | 2025-01-22 | 2025-01-21 | |
| 8-K | 2024-11-14 | — | |
| 10-Q | 2024-11-14 | 2024-09-30 | |
| 8-K | 2024-09-09 | — | |
| 10-Q | 2024-08-14 | 2024-06-30 | |
| 8-K | 2024-08-14 | — | |
| 8-K/A | 2024-07-09 | 2024-05-16 | |
| 8-K/A | 2024-07-09 | 2024-04-20 | |
| 8-K | 2024-06-05 | 2024-06-04 | |
| 8-K | 2024-05-16 | — | |
| 8-K | 2024-05-08 | — | |
| 10-Q | 2024-05-08 | 2024-03-31 | |
| 8-K | 2024-04-22 | 2024-04-20 | |
| 8-K | 2024-03-28 | — | |
| 10-K | 2024-03-28 | 2023-12-31 | |
| 8-K | 2024-01-30 | — |
Showing 1–42 of 42 filings
Key facts
CIK
1868279
CUSIP
04272N102
13F (30d)
141 filings
141 filers
Visit website
Investor relations